BioCorRx Announces the Appointment of Dr. Balbir S. Brar as VP of Drug Development
BioCorRx Inc. (OTCMKTS:BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that Dr. Balbir S. Brar has been appointed VP of Drug Development for the BioCorRx Pharmaceuticals subsidiary. Previously, Dr. Brar served as lead drug development study design consultant for the BioCorRx Pharmaceuticals subsidiary.
View full press release